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ABSTRACT 
 
The objective of the present hospital-based case-control study was to assess the association 
between glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphisms and 
susceptibility to pre-eclampsia (PE) in Shiraz (Fars province, southern Iran). A total of 200 
healthy pregnant women and 151 pre-eclamptic women were included. The healthy control 
group was frequency matched with the age of the pre-eclamptic women. Control women had 
neither PE in current pregnancy nor history of pregnancies with PE previously. The genotypes 
of GSTT1 and GSTM1 polymorphisms were determined using a PCR-based method. Neither 
GSTM1 null genotype (OR=1.07, 95 % CI: 0.70-1.64, P=0.736) nor GSTT1 null genotype 
(OR=0.73, 95 % CI: 0.44-1.21, P=0.233) was associated with risk of PE. Association between 
combination genotypes and risk of PE was not significant. When family history was entered 
as a covariate in analysis, adjusted ORs revealed that neither GSTM1 nor GSTT1 polymor-
phisms was associated with risk of PE. For meta-analysis, we identified 5 eligible studies, in-
cluding 1217 subjects (515 patients, and 702 healthy controls) in relation to the study poly-
morphisms and risk of PE. Our present meta-analysis indicated that there neither GSTM1 
(OR=0.99, 95 % CI: 0.78-1.25, P=0.955) nor GSTT1 polymorphisms (OR=0.85, 95 % CI: 
0.66-1.10, P=0.223) was associated with susceptibility to PE. Taken together it seems that the 
polymorphisms of GSTM1 and GSTT1 are not risk factors for PE. Further investigations ad-
justing for confounding factors are needed to confirm the present findings.  
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INTRODUCTION 
Pre-eclampsia (PE) is a major obstetric 
problem leading to substantial maternal and 
perinatal morbidity and mortality world-
wide, especially in developing countries. 
Clinically PE presents as a maternal syn-
drome, including hypertension and protein-
uria after second half of pregnancy. Based 
on family and twin studies pre-eclampsia 
was found to have a genetic component 
(Robert and Cooper, 2001; Sibai et al., 
2005). Consanguinity in terms of first 
cousin once removed increased the risk of 
PE, in comparison with unrelated marriages 
(Anvar et al., 2010). Genome-wide searches 
have identified several chromosomal bands 
associated with PE (Chappell and Morgan, 
2006; Mütze et al., 2008). 
Oxidative stress is known to take part of 
normal pregnant physiologic process. The 
pathophysiology of PE is known to be asso-
ciated with unbalanced between oxidative 
stress due to the production of reactive 
oxygen species and the ability of antioxi-
dant process (Dekker and Sibai, 1998; 
Chamy et al., 2006). Glutathione S-
transferases (GSTs) (EC: 2.5.1.18) are ma-
jor phase II enzymes involved in the detoxi-
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fication and are known as oxidative stress 
related genes (Hayes et al., 2005). Currently 
several classes of GSTs are known in hu-
man including mu and theta. Genetic poly-
morphisms in genes encoding GSTM1 (a 
member of class mu; MIM: 138350), and 
GSTT1 (a member of class theta; MIM: 
600436) have been defined. The GSTM1-0 
and GSTT1-0 alleles represent deletions of 
GSTM1 and GSTT1 genes, respectively and 
result in a loss of enzymatic activity (Ha-
rada et al., 1992; Pemble et al., 1994).  
Several studies have suggested that 
women who develop PE are at increased 
risk of cardiovascular complications later in 
life (Ramsay et al., 2003; Haukkamaa et al., 
2004). Epidemiological studies indicated 
that cancers, cardiovascular disease, and PE 
have common risk factors, including oxida-
tive stress (Squier 2001; Moskovitz et al., 
2002; Ramsay et al., 2003; Haukkamaa et 
al., 2004; Sibai et al., 2005). The GSTM1 
and GSTT1 null genotypes have been linked 
with an increased risk of several multifacto-
rial traits including cancers and cardiovas-
cular diseases (Harada et al., 1992; Wilson 
et al., 2000; Saadat et al., 2004a, b; Saadat 
and Farvardine-Jahromi, 2006; Saadat, 
2006, 2007; Unal et al., 2007; Wang et al., 
2008; Tang et al., 2010).  
Taken together, it is speculated that 
polymorphisms of GSTT1 and GSTM1 may 
be associated with risk of PE. Previously 
several studies have been conducted to as-
sess the role of GSTM1 and GSTT1 in PE. 
They found no relation between these 
polymorphisms and risk of PE (Zusterzeel 
et al., 2000; Cetin et al., 2005; Kim et al., 
2005; Zhang et al., 2008). Zusterzeel et al., 
(2000) found that the null genotype of 
GSTT1 significantly decreased the risk of 
PE. Therefore the association between 
GSTT1 and susceptibility to PE is an open 
question. However, there is no data on as-
sociation between susceptibility to PE and 
combination genotypes of GSTT1 and 
GSTM1. Therefore the present case-control 
study and meta-analysis were done. 
MATERIALS AND METHODS 
Case-control study 
In the present hospital-based case-
control study participants were recruited 
from the delivery ward at Zainabeieh and 
Hafez Hospitals, Shiraz University of 
Medical Sciences, between January 2009 
and January 2010. Pre-eclamptic cases 
(n=151) were defined as persistent blood 
pressure above 140/90 mmHg and proteinu-
ria of more than 0.3g/24h, developing after 
20 weeks of pregnancy (mean age + SD, 
28.1 + 5.4 years).  
Exclusion criteria were as follows: al-
tered renal function, chronic hypertension, 
hypercholesterolemia, cardiovascular dis-
eases, diabetes, asthma, cancers, cataract, 
psychiatric disorders such as schizophrenia 
and bipolar disease, twin pregnancies, re-
current miscarriages, fetal growth retarda-
tion, and abrutio placenta.  
A total of 200 healthy pregnant women 
frequency matched with the patients ac-
cording to age were also studied, as a con-
trol group (mean age + SD, 27.2 + 5.0 
years). Control women had neither PE in 
current pregnancy nor history of pregnan-
cies with PE previously. This study was ap-
proved by the institutional review board of 
local ethics committee at our department in 
Shiraz University. Informed consent was 
obtained from all participants.  
Because Iranian population is one of the 
most heterogeneous populations (Amirshahi 
et al., 1989; Walter et al., 1991; Mohama-
dynejad and Saadat, 2008; Rafiee et al., 
2010) we selected our patients and controls 
from the same ethnical religious group 
(Persian Muslims living in Fars province, 
southern Iran). At the time of blood dona-
tion, a brief questionnaire that ascertained 
age, history of cancers, cataract, and asthma 
was completed. We excluded patients and 
control subjects with cataract or past history 
of cataract surgery, asthma, past history of 
malignancy (treated or on treatment), car-
diovascular disease that on medication and 
known cases of glaucoma, because these 
traits were associated with GSTM1 and/or 
GSTT1 polymorphisms (Harada et al., 
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1992; Wilson et al., 2000; Saadat et al., 
2004a, b; Saadat and Farvardine-Jahromi, 
2006; Saadat, 2006, 2007; Unal et al., 2007; 
Wang et al., 2008; Tang et al., 2010).  
A woman with at least one first-degree 
relative with PE or own history of PE is 
considered to have a positive family his-
tory.  
 
Extraction of DNA and genotyping analy-
sis 
At the time of delivery, blood samples 
were obtained from participants and stored 
immediately at -80 °C. Genomic DNA was 
isolated from whole blood. The PCR condi-
tions for determining GSTT1 and GSTM1 
genotypes were the same as reported previ-
ously. The absence of amplified product 
was consistent with the null genotypes of 
GSTT1 and GSTM1. Successful amplifica-
tion by β-globin specific primers confirmed 
the proper function of the PCR reaction. 
Evaluating the polymorphism and labora-
tory quality control were the same as that 
reported previously (Rafiee et al., 2010).  
To ensure laboratory quality control, 
two independent readers interpreted the gel 
photographs. Any sample with ambiguous 
results was re-tested, and a random selec-
tion of 15 % of all samples was repeated, no 
discrepancy was discovered upon replicate 
testing (Rafiee et al., 2010). 
 
Statistical analysis 
The association between genetic poly-
morphisms and the risk of PE was exam-
ined by use of the odds ratios (OR) and 
95 % of confidence intervals (CIs). Because 
there was significant difference between 
patients and controls for family history for 
PE, the ORs were adjusted for family his-
tory for PE.  
To investigate whether one null geno-
type could be compensated by an active 
genotype for the other isoenzymes, we con-
sidered the association between combina-
tions of the genotypes and risk of PE. The 
reference group consisted of individuals 
who had two active genotypes. Also χ2 for 
linear trend for presence of 0, 1, and 2 null 
genotypes and risk of PE was calculated.  
Statistical analysis was performed using 
SPSS statistical software package (version 
11.5) for windows (SPSS Inc., Chicago, IL, 
USA). A probability of p < 0.05 was con-
sidered statistically significant. All P values 
were two-tailed. 
 
Identification of studies for meta-analysis  
Eligible studies were identified by 
searching the database of Medline database 
(US National Library of Medicine, Be-
thesda, Maryland), PubMed (National Cen-
ter for Biotechnology, National Library of 
Medicine), ISI Web of Knowledge, Elsevier 
ScienceDirect, EMBASE, EBSCOhost Re-
search Databases, Scopus, DOAJ (Directory 
of Open Access Journals), ProQuest, CAB 
Abstract, and SID (Scientific Information 
Database) for relevant reports published 
before April 2011 using the following 
search terms: "GSTT1", “GSTM1” "poly-
morphism", and "preeclampsia". Further-
more, references cited in the retrieved arti-
cles were screened to trace additional rele-
vant studies. 
The full texts of the candidate articles 
were examined to determine whether they 
contained sufficient information on the as-
sociation of simultaneously GSTT1 and 
GSTM1 polymorphisms and the risk of PE. 
Articles were included in the meta-analysis 
if they met all the following criteria: (1) un-
related case-control experimental design, 
(2) genotypic frequency documentation, (3) 
article published in English. Review arti-
cles, case-only articles, repeated literatures, 
and abstracts were excluded. All together, 4 
articles published in English met the inclu-
sion criteria (Zusterzeel et al., 2000; Cetin 
et al., 2005; Kim et al., 2005; Zhang et al., 
2008). The application of these criteria 
yielded 5 case-control studies eligible for 
meta-analysis. In all of the studies, the 
polymorphism was determined by PCR as-
says.  
All studies were reviewed twice and ex-
tracted the data using a standardized form. 
Data were collected on the authors, year of 
publication, country of origin, ethnicity and 
numbers of genotypes of GSTT1 and 
GSTM1 among cases and controls. 
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Statistical analysis  
The presence of between-study hetero-
geneity was investigated using the chi-
square-based Cochran’s Q statistic test 
(DerSimonian and Laird, 1986). The asso-
ciation was measured using random-effect 
or fixed-effect models according to the 
studies' heterogeneity. The fixed-effects 
method assumes no significant heterogene-
ity between the results of the individual 
studies being pooled, whereas, the random-
effects method allows for such heterogene-
ity. The fixed-effects and random-effects 
methods were used by Mantel-Haenszel 
(1959) and DerSimonian and Laird methods 
(1986), respectively. Possible causes of het-
erogeneity were investigated by subgroup 
analyses based on geographic location and 
ethnicity. 
 
RESULTS 
Case-control study 
Selective risk factors for PE were com-
pared between case and control groups (Ta-
ble 1). Family history of PE was signifi-
cantly associated with elevated of PE risk 
(OR=24.5, 95 % CI: 7.41-81.2, P < 0.001). 
There was no significant association be-
tween smoking status and PE (OR=0.37, 
95 % CI: 0.07-1.80, P=0.370).  
The prevalence of GSTM1 and GSTT1 
null genotypes were 50.5 and 26.0 percent, 
respectively, in control subjects. Among 
patients, the frequency of null genotypes of 
GSTM1 and GSTT1 were 52.3 and 20.5 
percent, respectively. Table 2 shows the 
association between the genetic polymor-
phisms and PE risk. Neither GSTM1 null 
genotype (OR=1.07, 95 % CI: 0.70-1.64, 
P=0.736) nor GSTT1 null genotype 
(OR=0.73, 95 % CI: 0.44-1.21, P=0.233) 
were associated with risk of PE. 
Considering that there was significant 
difference for family history for PE be-
tween cases and controls, the family history 
for PE of participants was used as a covari-
ate in further analysis. When family history 
was entered as a covariate in multivariate 
analysis, adjusted ORs revealed that neither 
GSTM1 (OR=1.16., 95 % CI: 0.73-1.85, 
P=0.512) nor GSTT1 polymorphisms 
(OR=0.76, 95 % CI: 0.44-1.32, P=0.338) 
were associated with risk of PE (Table 2). 
In order to investigate whether one null 
genotype could be compensated by an ac-
tive genotype for the other isoenzymes, in 
further analysis we study the association 
between genotypic combination and risk of 
PE. There was no association between 
combination genotypes and risk of PE be-
fore and after adjustment for family history 
for PE (Table 2). There was no linear trend 
for presence of 0, 1, and 2 null genotypes 
and risk of PE (χ2=0.251, P=0.616).  
 
 
 
Table 1: Comparisons of selective risk factors between pre-eclamptic patients and control subjects  
 
Characteristic Control Case OR 95 % CI P-value 
Family history of PE  
 
   
No 197 107  1.0   
Yes 3 40  24.5 7.41-81.2 <0.001 
Missing  0 4     
       
Parity       
Nulliparity 95 78  1.0   
Other parities 105 73  0.85 0.55-1.29 0.441 
       
Smoking habit       
No 193 149  1.0   
Yes 7 2  0.37 0.07-1.80 0.370 
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Table 2: Association between polymorphisms of GSTM1 and GSTT1 and risk of pre-eclampsia 
 
Genotypes  Control Case OR* 95% CI P-value OR** 95% CI P-value 
GSTM1 polymorphism   
 
   
 
   
Active  99 72  1.0    1.0   
Null  101 79  1.07 0.70-1.64 0.736  1.16 0.73-1.85 0.512 
            
GSTT1 polymorphism           
Active  148 120  1.0    1.0   
Null  52 31  0.73 0.44-1.32 0.233  0.76 0.44-1.32 0.338 
            
Combination of genotypes           
GSTM1 GSTT1           
Active Active 76 59  1.0    1.0   
Null Active 72 61  1.09 0.67-1.76 0.722  1.15 0.68-1.95 0.598 
Active Null 23 13  0.72 0.67-1.55 0.413  0.70 0.29-1.63 0.410 
Null Null 29 18  0.80 0.40-1.57 0.519  0.91 0.44-1.90 0.819 
* Crude OR                                  ** Adjusted OR after controlling for family history of PE 
 
 
Meta-analysis 
A database according to the extracted 
information from each article was estab-
lished. We identified 5 eligible studies 
(Zusterzeel et al., 2000; Cetin et al., 2005; 
Kim et al., 2005; Zhang et al., 2008; and 
present study), including 1217 subjects (515 
patients, and 702 healthy controls) in rela-
tion to the study polymorphisms and risk of 
PE, which are summarized in Table 3. From 
these, 3, 1, and 1 study were carried out in 
Asian, European and American countries, 
respectively (Table 3). The numbers in the 
case-control studies varied considerably 
(range 55 to 351 individuals). 
There was no significant heterogeneity 
between studies (Table 4). Our present 
meta-analysis indicated that there was no 
association between the GSTT1 polymor-
phism and PE risk among all studies 
(OR=0.85, 95 % CI: 0.66-1.10, P=0.223). 
One study was reported from Korea (Kim et 
al., 2005), the participants in other studies 
were Caucasians (Zusterzeel et al., 2000; 
Cetin et al., 2005; Zhang et al., 2008; and 
present study). Excluding this study re-
sulted a borderline association between 
GSTT1 polymorphism and risk of PE 
(OR=0.73, 95 % CI: 0.53-1.01, P=0.054). 
The overall ORs of the PE risk were not 
associated with the GSTM1 polymorphism 
among all studies (OR=0.99, 95 % CI: 
0.78-1.25, P=0.955) or among Caucasians 
(OR=1.0, 95 % CI: 0.76-1.31, P=1.0). 
 
 
Table 3: Studies used in the meta-analysis investigating the association between polymorphisms of 
GSTM1 and GSTT1 and risk of pre-eclampsia 
 
Study Country Ethnicity  Control  Patients  OR 95 % CI P-value 
GSTT1 polymorphism   Active Null   Active Null     
Zusterzeel et al., 
2000 
Nether-
lands 
Caucasian  76 33  67 34  0.44 0.21-0.91 0.029 
Kim et al., 2005 Korea Asian  97 117  51 70  1.13 0.72-1.78 0.574 
Cetin et al., 2005 Turkey Caucasian  114 33  109 31  0.98 0.56-1.71 0.950 
Zhang et al., 2008 USA Caucasian  25 7  19 4  0.68 0.19-2.94 0.682 
Current study Iran Caucasian  148 52  120 31  0.73 0.44-1.21 0.233 
             
GSTM1 polymorphism    Active Null  Active Null     
Zusterzeel et al., 
2000 
Nether-
lands 
Caucasian  52 57  46 74  0.67 0.37-1.20 0.184 
Kim et al., 2005 Korea Asian  103 111  59 62  0.97 0.62-1.52 0.912 
Cetin et al., 2005 Turkey Caucasian  66 81  59 81  1.11 0.70-1.78 0.638 
Zhang et al., 2008 USA Caucasian  26 6  17 6  1.52 0.42-5.53 0.517 
Current study Iran Caucasian  99 101  72 79  1.07 0.70-1.64 0.736 
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Table 4: Summary of meta-analysis of case-control studies examining GSTT1 and GSTM1 poly-
morphisms and pre-eclampsia risk 
 
Studies Number of studies  Q-statistics OR 95 % CI P-value 
GSTT1 polymorphism       
All studies 5  5.275 0.85 0.66-1.10 0.223 
Caucasians 4  2.877 0.73 0.53-1.01 0.054 
       
GSTM1 polymorphism       
All studies 5  2.530 0.99 0.78-1.25 0.955 
Caucasians 4  2.520 1.0 0.76-1.31 1.0 
 
DISCUSSION 
Our present case-control study showed 
that family history of PE was significantly 
associated with elevated of PE risk, con-
firming previous reports (Robert and Coo-
per 2001; Sibai et al., 2005). We found that 
there was no significant association be-
tween smoking status and PE, which is not 
in agreement with previous reports (Robert 
and Cooper, 2001; Sibai et al., 2005). The 
discrepancy may be explained by very low 
prevalence of smokers among Iranian popu-
lation. The observed prevalence for GSTT1 
and GSTM1 null genotypes among control 
subjects were similar to other studies re-
ported form Iran (Saadat et al., 2004a; 
Saadat and Farvardine-Jahromi, 2006; 
Saadat, 2006, 2007; Rafiee et al., 2010). 
Neither GSTM1 nor GSTT1 null genotypes 
were associated with risk of PE (Table 2). 
Our results are in concordance with previ-
ous studies investigating susceptibility to 
PE and genetic polymorphisms of GSTM1 
and GSTT1 (Cetin et al., 2005; Kim et al., 
2005; Zhang et al., 2008). 
Previously it is reported that GSTs may 
have substrate overlapping (Hayes et al., 
2005), also the additive effects of GSTM1 
and GSTT1 polymorphisms on risk of sev-
eral multifactorial traits were reported (Wil-
son et al., 2000; Saadat et al., 2004b; Saadat 
2007; Masoudi et al., 2010). Therefore we 
investigate whether one null genotype could 
be compensated by an active genotype for 
the other isoenzymes, in further analysis we 
study the association between genotypic 
combination and risk of PE. There was no 
association between combination genotypes 
and risk of PE before and after adjustment 
for family history for PE. 
The present finding from our case-
control study showed that there is no evi-
dence that one null genotype could be com-
pensated by an active genotype for the other 
isoenzymes. This means that genetic poly-
morphisms of GSTM1 and GSTT1 are not 
risk factors for PE. It should be noted that 
there are many important risk factors for PE 
(Dekker and Sibai, 1998; Robert and Coo-
per, 2001; Moskovitz et al., 2002; Sibai et 
al., 2005; Chappell and Morgan, 2006; 
Chamy et al., 2006; Mütze et al., 2008) and 
in the present study we investigate only the 
possible confounding effect of family his-
tory on the association between GSTs 
polymorphisms and susceptibility to PE. 
Further investigations adjusting for con-
founding factors are needed to confirm the 
finding of the present study. 
The studies investigating the association 
between GSTT1 and GSTM1 polymor-
phisms and susceptibility to PE are limited 
by small sample sizes (Zusterzeel et al., 
2000; Cetin et al., 2005; Kim et al., 2005; 
Zhang et al., 2008), so there is a role for 
meta-analysis in pooling these studies, par-
ticularly to detect the small effect sizes that 
may be associated with these polymor-
phisms. There was no evidence of hetero-
geneity between studies used for meta-
analysis. The present meta-analysis showed 
that neither GSTT1 nor GSTM1 polymor-
phisms were associated with susceptibility 
to PE. Finally it should be noted that the 
number of subjects, in the present meta-
analysis is about 1217, which is much 
lower than the required samples. This war-
rants further investigation in larger studies.  
EXCLI Journal 2011;10:44-51 – ISSN 1611-2156 
Received: March 15, 2011, accepted: April 18, 2011, published: April 20, 2011 
 
50 
ACKNOWLEDGEMENTS 
The authors are indebted to the partici-
pants for their close cooperation. The au-
thors are indebted to Dr. Maryam Ansari-
Lari for critical reading of the manuscript 
and for her contribution in discussion. This 
study was supported by Shiraz University.   
 
CONFLICT OF INTEREST 
All authors declare that they have no 
conflict of interest.  
 
REFERENCES 
Amirshahi P, Sunderland E, Farhud DD, 
Tavakoli SH, Daneshmand P, Papiha SS. 
Serum proteins and erythrocyte enzymes of 
populations in Iran. Hum Hered 1989;39: 
75-80. 
 
Anvar Z, Namavar-Jahromi B, Saadat M. 
Association between consanguineous mar-
riages and risk of pre-eclampsia. Arch Gy-
necol Obstet [Epub ahead of print] 2010. 
 
Cetin M, Pinarbasi E, Percin FE, Akgün E, 
Percin S, Pinarbasi H, Gurlek F, Cetin A. 
No association of polymorphisms in the 
glutathione S-transferase genes with pre-
eclampsia, eclampsia and HELLP syn-
drome in a Turkish population. J Obstet 
Gynaecol Res 2005;31:236-41.  
 
Chamy VM, Lepe J, Catalan A, Retamal D, 
Escobar JA, Madrid EM. Oxidative stress is 
closely related to clinical severity of pre-
eclampsia. Biol Res 2006;39:229-36.  
 
Chappell S, Morgan L. Searching for ge-
netic clues to the causes of pre-eclampsia. 
Clin Sci (Lond) 2006;110:443-58. 
 
Dekker GA, Sibai BM. Etiology and patho-
genesis of preeclampsia: current concepts. 
Am J Obstet Gynecol 1998;179:1359-75. 
 
DerSimonian R, Laird N. Meta-analysis in 
clinical trials. Contr Clin Trials 1986;7:177-
88. 
 
Harada S, Misawa S, Nakamura T, Tanaka 
N, Ueno E, Nozoe M. Detection of GST1 
gene deletion by the polymerase chain reac-
tion and its possible correlation with stom-
ach cancer in Japanese. Hum Genet 1992; 
90:62-4. 
 
Haukkamaa L, Salminen M, Laivuori H, 
Leinonen H, Hiilesmaa V, Kaaja R. Risk 
for subsequent coronary artery disease after 
pre-eclampsia. Am J Cardiol 2004;93:805-
8. 
 
Hayes JD, Flanagan JU, Jowsey IR. Glu-
tathione transferases. Annu Rev Pharmacol 
2005;45:51-88. 
 
Kim YJ, Park HS, Park MH, Suh SH, Pang 
MG. Oxidative stress-related gene poly-
morphism and the risk of preeclampsia. Eur 
J Obstet Gynecol Reprod Biol 2005;119:42-
6. 
 
Mantel N, Haenszel W. Statistical aspects 
of the analysis of data from retrospective 
studies of disease. J Natl Cancer Inst 1959; 
22:719-48. 
 
Masoudi M, Saadat I, Omidvari S, Saadat 
M. Additive effects of genetic variations of 
xenobiotic detoxification enzymes and 
DNA repair gene XRCC1 on the suscepti-
bility to breast cancer. Breast Cancer Res 
Treat 2010;120:263-5. 
 
Mohamadynejad P, Saadat M. Genetic 
polymorphisms of XRCC1 (at codons 194 
and 399) in Shiraz population (Fars prov-
ince, southern Iran). Mol Biol Rep 2008; 
35:669-72. 
 
Moskovitz Y, Yim MB, Chock PB. Free 
radicals and disease. Arch Biochem Bio-
phys 2002;397:354-9. 
 
Mütze S, Rudnik-Schöneborn S, Zerres K, 
Rath W. Genes and the pre-eclampsia syn-
drome. J Perinat Med 2008;36:38-58.  
 
EXCLI Journal 2011;10:44-51 – ISSN 1611-2156 
Received: March 15, 2011, accepted: April 18, 2011, published: April 20, 2011 
 
51 
Pemble S, Schroeder KR, Spencer SR, 
Meyer DJ, Hallier E, Bolt HM, Ketterer B, 
Taylor JB. Human glutathione S-transferase 
theta (GSTT1): cDNA cloning and the char-
acterization of a genetic polymorphism. 
Biochem J 1994;300:271–6.  
 
Rafiee L, Saadat I, Saadat M. Glutathione 
S-transferase genetic polymorphisms 
(GSTM1, GSTT1 and GSTO2) in three Ira-
nian populations. Mol Biol Rep 2010;37: 
155-8. 
 
Ramsay JE, Stewart F, Greer IA, Sattar N. 
Microvascular dysfunction: a link between 
pre-eclampsia and maternal coronary heart 
disease. BJOG 2003;110:1029-31. 
 
Robert JM, Cooper DW. Pathogenesis and 
genetics of preelampsia. Lancet 2001;357: 
53-6. 
 
Saadat M. Genetic polymorphisms of glu-
tathione S-transferase T1 (GSTT1) and sus-
ceptibility to gastric cancer: a meta-
analysis. Cancer Sci 2006;97:505-9. 
 
Saadat M. Influence of glutathione S-
transferase T1 and M1 on serum lipid pa-
rameters. Saudi Med J 2007;28:1645-7. 
 
Saadat M, Farvardine-Jahromi M. Poly-
morphism of glutathione S-transferase M1, 
occupational exposure to sunlight, and se-
nile cataract risk. Occup Environ Med 
2006;63:503-4.  
 
Saadat M, Farvardin-Jahromi M, Saadat H. 
Null genotype of glutathione S-transferase 
M1 is associated with senile cataract sus-
ceptibility in non-smoker females. Biochem 
Biophys Res Commun 2004a;319:1287-91. 
 
Saadat M, Saadat I, Saboori Z, Emad A. 
Combination of CC16, GSTM1 and GSTT1 
polymorphisms is associated with asthma. J 
Allergy Clin Immunol 2004b;113:996-8. 
Sibai B, Dekker G, Kupferminc M. Pree-
clampsia. Lancet 2005;365:785-99. 
 
Squier TC. Oxidative stress and protein ag-
gregation during biological aging. Exp 
Gerontol 2001;36:1539-50. 
 
Tang JJ, Wang MW, Jia EZ, Yan JJ, Wang 
QM, Zhu J, Yang ZJ, Lu X, Wang LS. The 
common variant in the GSTM1 and GSTT1 
genes is related to markers of oxidative 
stress and inflammation in patients with 
coronary artery disease: a case-only study. 
Mol Biol Rep 2010;37:405-10. 
 
Unal M, Güven M, Devranoğlu K, Ozaydin 
A, Batar B, Tamçelik N, Görgün EE, Uçar 
D, Sarici A. Glutathione S transferase M1 
and T1 genetic polymorphisms are related 
to the risk of primary open-angle glaucoma: 
a study in a Turkish population. Br J Oph-
thalmol 2007;91:527-30.  
 
Walter H, Farhud DD, Danker-Hopfe H, 
Amirshahi P. Investigations on the ethnic 
variability of the ABO blood group poly-
morphism in Iran. Z Morphol Anthropol 
1991;78:289-306. 
 
Wang LS, Tang JJ, Tang NP, Wang MW, 
Yan JJ, Wang QM, Yang ZJ, Wang B. As-
sociation of GSTM1 and GSTT1 gene 
polymorphisms with coronary artery dis-
ease in relation to tobacco smoking. Clin 
Chem Lab Med 2008;46:1720-5. 
 
Wilson MH, Grant PJ, Haridie LJ, Wild CP. 
Glutathione S-transferase M1 null genotype 
is associated with a decreased risk of myo-
cardial infraction. FASEB J 2000;14:791-6.  
 
Zhang J, Masciocchi M, Lewis D, Sun W, 
Liu A, Wang Y. Placental anti-oxidant gene 
polymorphisms, enzyme activity, and oxi-
dative stress in preeclampsia. Placenta 
2008;29:439-43.  
 
Zusterzeel PLM, Visser W, Peteres WHM, 
Merkus HWMJ. Polymorphism in the Glu-
tathione S-transferase P1 gene and risk for 
preeclampsia. Obstet Gynecol 2000;96:50-
4. 
